SJ 733Alternative Names: (+)-SJ 000557733; SJ-557733; SJ-733
Latest Information Update: 18 Aug 2016
At a glance
- Originator St. Jude Childrens Research Hospital
- Developer Eisai Co Ltd; Medicines for Malaria Venture; QIMR Berghofer Medical Research Institute; St. Jude Childrens Research Hospital
- Class Antimalarials; Isoquinolines; Small molecules
- Mechanism of Action Calcium-transporting ATPase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Malaria